logo inner

Senior Director, Translational Biology


Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility.
Cytokinetics was founded by four pioneers in cell biology whose academic research and discoveries contributed to the scientific platform for our company. For more than 25 years, our scientists have built on their seminal work to pioneer potential medicines targeting muscle function. Today, we continue to look for tenacious scientists who are driven to push the boundaries of innovation for the benefit of patients.As the Sr. Director of Discovery Translational Biology, the candidate will lead a team focused on causal human biology to identify and validate targets and biomarkers for treatment of cardiovascular and neuromuscular diseases.

The candidate will be a member of Biology Research Leadership Team and is expected to have broad impact on strategies in biology, assay development, pharmacology, and clinical development by employing human data from biobanks to identify novel therapeutic targets, biomarkers of disease progression, and patient stratification. Candidate should have strong leadership skills, demonstrated record of identifying and investigating causal genotype-phenotype associations captured from large human datasets, and translating them into novel therapeutic strategies for patients. We are seeking a candidate with background in human genetics and biology to join the vibrant research team at Cytokinetics that values collaboration, rigor, and interdisciplinary approaches to discover and develop novel therapeutics for patients with cardiovascular and neuromuscular diseases. 

Responsibilities:


  • Lead a team focused on causal human biology and oversee their research efforts
  • Direct investigations in genotype-phenotype associations for cardiovascular and neuromuscular diseases using datasets in public biobanks
  • Propose and validate new targets and biomarker strategies
  • Provide scientific and clinical insights into on-going discovery and clinical research programs  
  • Recruit top talent focused on interrogation of human genetics and biology for therapeutic application
  • Enhance our fundamental understanding of cardiovascular and neuromuscular diseases
  • Collaborate closely with other scientists in Discovery Biology, Biology Technologies, Pharmacology, Medicinal Chemistry, DMPK, Toxicology, and Discovery Informatics to build Cytokinetics research portfolio
  • Promote and prioritize team-driven translational of discoveries into effective therapeutics

Qualifications


  • MD/PhD or PhD with training in human genetics, computational biology, molecular and cell biology with proven record of target discovery and validation
  • A respected and rising leader in academia and/or industry with 12+ years of professional experience
  • Hands-on experience in designing, conducting, analyzing, and interpreting data from large human datasets
  • Proven record of executing target validation strategies using cutting-edge technologies
  • Experienced team builder and manager of highly engaged scientists
  • A critical thinker with demonstrated record of creative scientific achievement
  • Demonstrated ability to bridge between basic and clinical research with ease
  • Passionate about discovering and developing novel therapeutics for patients
  • Excellent verbal and written communication skills, including presentation skills to peer groups

Our passion is anchored in rigorous and diligent scientific and clinical approaches to the discovery and development of novel mechanism therapeutics. With gratitude for the commitments and convictions of our employees who are inspired by the courage of patients we aim to serve, we believe Cytokinetics will continue to be a pioneering, values-driven, sustainable, fully integrated biopharmaceutical company.

Please visit our website at: www.cytokinetics.com


Cytokinetics is an Equal Opportunity Employer


Actual salary at the time of hire may vary and may be above or below the range based on various factors, including, but not limited to, the candidate’s relevant qualifications, skills, and experience, as well as the service line and location where this position may be filled.Salary Pay Range$285,000 - $315,000USDOur employees come from different backgrounds, and we celebrate those differences. We are looking for the best candidates for our open roles, but do not expect applicants to meet every qualification in order to be considered.

If you are excited about what you could accomplish at Cytokinetics and believe you can add value to our team, we would love to hear from you.

Please review our General Data Protection Regulation (GDPR) policy PRIOR to applying.  


Our passion is anchored in robust scientific thinking, grounded in integrity and critical thinking. We keep the patient front and center in all we do – all actions and decisions are in service of the patient and their caregivers. We champion integrity, ethics, doing the right thing, and being our best selves.

Fraud Warning: How to Identify Impersonated Cytokinetics Job Postings and Offers


Recently, there have been fraudulent employment offers being sent to candidates on behalf of Cytokinetics. Please be advised that all legitimate offers from Cytokinetics will come directly from our official email domain (Cytokinetics.com) and will only be made after completing a formal interview process.Here are some ways to check for authenticity:

  • We do not conduct job interviews through non-standard text messaging applications
  • We will never request personal information such as banking details until after an official offer has been accepted and verified
  • We will never request that you purchase equipment or other items when interviewing or hiring
  • If you are unsure about the authenticity of an offer, or if you receive any suspicious communication, please contact us directly at talentacquisition@cytokinetics.com

Please visit our website at: www.cytokinetics.com


Cytokinetics is an Equal Opportunity Employer



Life at Cytokinetics

We are a leading biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that specifically target the cytoskeleton. The cytoskeleton is a complex biological infrastructure that plays a fundamental role within every human cell. A number of commonly used drugs and a growing body of research validate the role that the cytoskeleton plays in a wide array of human diseases. Our focus on the cytoskeleton enables us to develop novel and potentially safer and more effective classes of drugs directed at treatments for cancer, cardiovascular disease, fungal diseases and other diseases. We have developed a cell biology driven approach and proprietary technologies to evaluate the function of many interacting proteins in the complex environment of the intact human cell. We believe that our approach enhances the speed, efficiency and yield of our drug discovery and development process by accurately and rapidly identifying drug candidates with attractive properties. Our approach has yielded two drug candidates for the treatment of cancer, a drug candidate for the treatment of acute congestive heart failure and more than ten other research programs. Our most advanced drug candidate, SB-715992, is the subject of a broad Phase II clinical trials program designed to evaluate its effectiveness in many different types of cancer. An investigational new drug application, or IND, was filed with the U.S. Food and Drug Administration, or FDA, in 2003 for our second cancer drug candidate, SB-743921, which we expect will enter Phase I clinical development in early 2004. SB-715992 and SB-743921 are being developed through our strategic alliance with GlaxoSmithKline. In addition, we expect to initiate Phase I clinical development for a drug candidate, CK-1213296, for the treatment of acute congestive heart failure in the second half of 2004.
Thrive Here & What We Value1. Passionate about robust scientific thinking grounded in integrity and critical thinking2. Celebrates differences among employees3. Patient-centric approach to all actions and decisions4. Values integrity, ethics, doing the right thing, and being our best selves5. Emphasis on patient-centered care6. Focus on innovation and continuous improvement7. Dedicated to keeping the patient front and center in all actions and decisions8. Values-driven and sustainable approach to drug discovery and development9. Rigorous scientific thinking and critical thinking10. Emphasis on collaboration across different departments and teams
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2024